Company Filing History:
Years Active: 1982-1991
Title: Masatoshi Tsujino: Innovator in Nucleoside-Phospholipid Conjugates
Introduction
Masatoshi Tsujino is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of nucleoside-phospholipid conjugates. With a total of 7 patents to his name, Tsujino's work has the potential to impact various pharmaceutical applications.
Latest Patents
Tsujino's latest patents include innovative formulations of nucleoside-phospholipid conjugates. One notable patent describes a novel nucleoside-phospholipid conjugate characterized by the formula ##STR1##, where R.sub.1 is a C.sub.14-24 long chain aliphatic acyl or C.sub.1-24 aliphatic alkyl, R.sub.2 is a C.sub.2-10 aliphatic acyl or C.sub.1-24 aliphatic alkyl, and N.sub.s represents a nucleoside residue. This conjugate is prepared through a one-step reaction involving the corresponding nucleoside and glycerophospholipid derivative in the presence of phospholipase D-P. Another patent focuses on a similar nucleoside-phospholipid conjugate, emphasizing its pharmacologically acceptable salts and the efficiency of the one-step reaction process.
Career Highlights
Masatoshi Tsujino is affiliated with Toyo Jozo Kabushiki Kaisha, where he continues to advance his research and development efforts. His work has garnered attention for its innovative approach to drug formulation and delivery systems. Tsujino's expertise in biochemistry and his dedication to research have positioned him as a key figure in his field.
Collaborations
Tsujino has collaborated with notable colleagues, including Kiyofumi Fukukawa and Satoshi Shuto. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality and impact of their research.
Conclusion
Masatoshi Tsujino's contributions to the field of nucleoside-phospholipid conjugates exemplify the importance of innovation in biochemistry. His patents reflect a commitment to advancing pharmaceutical science and improving drug delivery systems.